Clinical Trial

Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, multicentre, randomized clinical trial evaluating the safety, tolerability, and efficacy of up to 12 weeks treatment with SoC + low- or high-dose CYWC628 in treating DFU, compared to SoC only.
Trial Details
NCT Number NCT07096934
Lead Sponsor FibroBiologics
Conditions Diabetic Foot Ulcer (DFU)
Enrollment 120 participants
Start Date 2025-09
Primary Completion 2026-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-07-31